Paper896122
Serum complement levels in patients with digestive tract carcinomas and other neoplastic diseases.
Maness PF and 1 other. Oncology, 1977. Cited by 20 papers, by iCite.
Cite this record
ConductScience Library. Serum complement levels in patients with digestive tract carcinomas and other neoplastic diseases. Papers, record 896122. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/896122
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Serum complement levels in patients with digestive tract carcinomas and other neoplastic diseases.
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Colonic Neoplasms | Major topic |
| Complement System Proteins | Major topic |
| Neoplasms | Major topic |
| Stomach Neoplasms | Major topic |
| Adenocarcinoma | |
| Esophageal Neoplasms | |
| Female | |
| Humans | |
| Male | |
| Sex Factors |
Source PubMed
Cited by8
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 20 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41526546 | The contribution of the membrane-bound complement regulatory proteins CD46 and CD55 in phases of acute lymphocytic leukemia and acute myelogenous leukemia. | Sci Rep | 2026 | https://conductscience.org/library/papers/41526546 | PubMed |
| 37357623 | Complement system in Anti-CD20 mAb therapy for cancer: A mini-review. | Int J Immunopathol Pharmacol | 2023 | https://conductscience.org/library/papers/37357623 | PubMed |
| 27043541 | Identification of Serum Peptidome Signatures of Non-Small Cell Lung Cancer. | Int J Mol Sci | 2016 | https://conductscience.org/library/papers/27043541 | PubMed |
| 24272362 | The role of complement in tumor growth. | Adv Exp Med Biol | 2014 | https://conductscience.org/library/papers/24272362 | PubMed |
| 23706991 | Complement inhibition in cancer therapy. | Semin Immunol | 2013 | https://conductscience.org/library/papers/23706991 | PubMed |
| 17030172 | Increased serum levels of complement C3a anaphylatoxin indicate the presence of colorectal tumors. | Gastroenterology | 2006 | https://conductscience.org/library/papers/17030172 | PubMed |
| 7379328 | Circulating immune complexes, complement and complement component levels in childhood Hodgkin's disease. | Clin Exp Immunol | 1980 | https://conductscience.org/library/papers/7379328 | PubMed |
| 109056 | Nutritional status and the nonspecific cellular and humoral immune response in esophageal carcinoma. | Ann Surg | 1979 | https://conductscience.org/library/papers/109056 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/896122
GET https://conductscience.org/api/papers/v1/896122/authors